Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
04/2004
04/13/2004US6720181 Ubiquitin ligases as therapeutic targets
04/13/2004US6720175 Mediating receptor-activated or ion channel-mediated intracellular calcium mobilization or concentration.
04/13/2004US6720167 Nucleic acid sequence comprising in order a b. thuringiensis cry promoter; a bacteria stab-si sequence, a ribosome binding site, and a sequence encoding one or both proteins of a b. sphaericus binary toxin.
04/13/2004US6720151 Therapeutic agents that inhibit the tup1 pathway
04/13/2004US6720146 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of ovarian cancer
04/13/2004US6720014 Culturing escherichia coli; genetic engineering and expression
04/13/2004US6719983 VMP-like sequences of pathogenic Borrelia
04/13/2004US6719968 For therapy of tendinitis, or other tendon or ligament defect
04/13/2004CA2291608C Neurotrophic factor receptors
04/13/2004CA2195076C Process for modifying the stability of antibodies
04/08/2004WO2004029278A2 Aav itr-mediated modulation
04/08/2004WO2004029273A1 Production method of iturin a and its homologues
04/08/2004WO2004029271A1 Recombinant microorganism for the production of vitamin b6
04/08/2004WO2004029252A2 A gene encoding vitamin b6 phosphate phosphatase and use thereof
04/08/2004WO2004029251A1 Fructosylamine oxidase
04/08/2004WO2004029240A1 Method of obtaining yeast biocapsules, biocapsules thus obtained and applications of same
04/08/2004WO2004029228A1 Microorganism and process for preparing vitamin b6
04/08/2004WO2004029227A1 Grass endophytes
04/08/2004WO2004028460A2 Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
04/08/2004WO2004028447A2 Novel compositions and methods for the treatment of psoriasis
04/08/2004WO2004020643A3 Regulated bacterial lysis for gene vaccine vector delivery and antigen release
04/08/2004WO2004003139A3 Modified shine-dalgarno sequences and methods of use thereof
04/08/2004WO2004000096A3 Novel bartonella antigen lysate extracts for use in elisa diagnostic
04/08/2004WO2003106684A3 A method for simultaneous production of multiple proteins; vectors and cells for use therein
04/08/2004WO2003104428A3 Gene differentially expressed in breast and bladder cancer and encoded polypeptides
04/08/2004WO2003100087A3 Regulation of novel human asparagine-hydroxylases
04/08/2004WO2003100023A3 Manipulation of the rate of gastrointestinal transit by modulating intestinal methane concentration
04/08/2004WO2003100008A3 Neutralizing human anti-igfr antibody
04/08/2004WO2003092600A3 Site specific listeria integration vectors and methods for using the same
04/08/2004WO2003087386A3 Methods for producing sulphurous fine chemicals by fermentation using meth-coding coryneform bacteria
04/08/2004WO2003087144A3 Insecticide proteins from photorabdus luminescens
04/08/2004WO2003076610A3 Variants of human kallikrein-2 and kallikrein-3 and uses thereof
04/08/2004WO2003070974A3 Mismatch repair detection
04/08/2004WO2003070925A3 Identification of 3-ketosteroid 9-alfa-hydroxylase genes and microorganisms blocked in 3-ketosteroid 9-alfa-hydroxylase activity
04/08/2004WO2003064468A3 The ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3), its crystal structure, and uses thereof
04/08/2004WO2003057900A3 Pseudomonas virulence factors and uses thereof
04/08/2004WO2003056336A3 Improved structured-functional bonding matrices for biomolecules
04/08/2004WO2003053158A9 Malleable protein matrix and uses thereof
04/08/2004WO2003042249A8 Peptide purification by means of metal ion affinity chromatography
04/08/2004WO2003007699A3 Transcription factors of cereals
04/08/2004WO2002099074A8 Slc7s as modifiers of the p53 pathway and methods of use
04/08/2004WO2002090545A3 Nucleic acid coding for the cgl1 polypeptide and diagnostic and therapeutic application of said nucleic acid and of the cgl1 polypeptide
04/08/2004WO2002083854A3 Antibodies to vla-1
04/08/2004WO2002081668A9 Desaturase genes and uses thereof
04/08/2004WO2002076391B1 Microbial feeds for aquaculture and agriculture
04/08/2004WO2002073154A3 Method and the detection of bacteria and bacterial groups
04/08/2004WO2002072792A9 Heterologous fusion protein constructs comprising a leishmania antigen
04/08/2004US20040067851 Powdered, hermetically sealed transgenic aspergillus and/or tolypocladium comprising pesticides for killing plant pests and increasing crop yields; pollution control
04/08/2004US20040067589 Method of altering levels of plasmids
04/08/2004US20040067576 Polyhydroxyalkanoate, method for production thereof and microorganisms for use in the same
04/08/2004US20040067566 Process for producing coenzyme q10
04/08/2004US20040067562 Process for the production of L-lysine using coryneform bacteria
04/08/2004US20040067561 Producing amino acids by fermentation using coryneform bacteria that are sensitive to 4-hydroxy-diaminopimelic acid
04/08/2004US20040067558 Used as a raw material of an anti-virus agent, antisense medicine
04/08/2004US20040067555 Recombinant hosts suitable for simultaneous saccharification and fermentation
04/08/2004US20040067552 Adipocyte complement related protein zacrp14
04/08/2004US20040067524 Chlamydia protein, gene sequence and uses thereof
04/08/2004US20040067518 Isolated nucleic acid comprising a polynucleotide of given sequence; polypeptides; recombinant host cells; useful in diagnosing and treating disorders
04/08/2004US20040067515 Human proteinase molecules
04/08/2004US20040067504 Novel zacrp8 polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods of using them; useful in the study of collagen dimerization or oligomerization or in formation of fusion proteins
04/08/2004US20040067490 Nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, their derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide
04/08/2004US20040067217 Chimeric cell-targeting pathogenic organism and method of therapeutic use
04/08/2004CA2503510A1 Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
04/08/2004CA2500397A1 Aav itr-mediated modulation
04/08/2004CA2499623A1 Novel compositions and methods for the treatment of psoriasis
04/07/2004EP1405914A1 Nucleic acid sequences and expression systems for heparinase II and heparinase III derived from flavobacterium heparinum
04/07/2004EP1405913A2 Process for improving the production of 5R clavams
04/07/2004EP1405911A1 Interaction trap systems for detecting protein interactions
04/07/2004EP1405864A1 Process for decreasing the reducing sugars content of light steepwater
04/07/2004EP1404876A2 Interferon alpha-14 polymorphism
04/07/2004EP1404868A2 Compositions and methods relating to osteoarthritis
04/07/2004EP1404858A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
04/07/2004EP1404857A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
04/07/2004EP1404856A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
04/07/2004EP1404846A1 Method for obtaining cells with new properties
04/07/2004EP1404844A2 Process for the preparation of 2,4-dideoxyhexoses and 2,4,6-trideoxyhexoses
04/07/2004EP1404840A2 Process for the preparation of d-pantothenic acid and/or salts thereof
04/07/2004EP1404839A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
04/07/2004EP1404838A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family with enhanced fba expression
04/07/2004EP1404837A2 Process for the preparation of l-amino acids using strains of the enterobacterialceae family with enhanced pts-g expression
04/07/2004EP1404836A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
04/07/2004EP1404835A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family with enhanced mop-b expression
04/07/2004EP1404834A2 Nucleic acid coding for the cgl1 polypeptide and diagnostic and therapeutic application of said nucleic acid and of the cgl1 polypeptide
04/07/2004EP1404833A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
04/07/2004EP1404831A2 Type 2 cytokine receptor and nucleic acids encoding same
04/07/2004EP1404829A1 Novel aminopeptidase derived from bacillus licheniformis, gene encoding the aminopeptidase, expression vector containing the gene, transformant and method for preparation thereof
04/07/2004EP1404827A2 Lipolytic enzyme genes
04/07/2004EP1404821A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
04/07/2004EP1404808A2 Nucleic acid free ghost preparations
04/07/2004EP1404806A1 Male contraceptives
04/07/2004EP1404805A2 Automated imaging and harvesting of colonies of thin film culture devices
04/07/2004EP1404716A2 Novel g protein-coupled receptors and dna sequences thereof
04/07/2004EP1404714A2 Nuclear hormone receptor ligand binding domain
04/07/2004EP1404706A2 Mycobacterial antigens expressed during latency
04/07/2004EP1404703A2 G-protein coupled receptors
04/07/2004EP1404663A1 Eurotinone and derivatives thereof, method for the production and use of the same
04/07/2004EP1404375A1 Imaging infection using fluorescent protein as a marker
04/07/2004EP1404368A2 Mutant forms of cholera holotoxin as an adjuvant
04/07/2004EP1404358A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
04/07/2004EP1404350A2 Proteins associated with cell growth, differentiation, and death